EPA:LHYFE • FR0014009YQ1
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LHYFE SAS (LHYFE.PA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-26 | PORTZAMPARC BNP PARIBAS | Maintains | Buy -> Buy |
| 2025-04-07 | Bryan Garnier | Maintains | Neutral -> Neutral |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 570K 189.34% | 1.317M 131.05% | 5.099M 287.17% | 10.97M 115.14% | 21.63M 97.17% | 63.294M 192.62% | 258.5M 308.41% | 333.75M 29.11% | 464.99M 39.32% | 558.69M 20.15% | 712.03M 27.45% | |
| EBITDA YoY % growth | -18.012M -232.88% | -30.793M -70.96% | -24.269M 21.19% | -28.274M -16.50% | -15.502M 45.17% | -3.296M 78.74% | 26.33M 898.85% | 47.114M 78.94% | 68.491M 45.37% | 115.34M 68.40% | 174.58M 51.36% | |
| EBIT YoY % growth | -19.165M -237.41% | -34.37M -79.34% | -28.975M 15.70% | -39.398M -35.97% | -24.257M 38.43% | -14.266M 41.19% | -48.421M -239.43% | -28.096M 41.98% | -7.202M 74.37% | 39.144M 643.53% | 97.846M 149.96% | |
| Operating Margin | -3,362.28% | -2,609.72% | -568.25% | -359.14% | -112.14% | -22.54% | -18.73% | -8.42% | -1.55% | 7.01% | 13.74% | |
| EPS YoY % growth | N/A | N/A -102.60% | N/A 1.54% | -0.74 6.25% | -0.59 20.83% | -0.44 24.56% | N/A | N/A | N/A | N/A | N/A |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
10 analysts have analysed LHYFE.PA and the average price target is 4.08 EUR. This implies a price increase of 60.63% is expected in the next year compared to the current price of 2.54.
LHYFE SAS (LHYFE.PA) will report earnings on 2026-03-31.
The expected long term growth rate for LHYFE SAS (LHYFE.PA) is 130.16%.